Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. scores highest on Nitro (99) and lowest on Price (45). Its PosiPenta is 74.33 out of 100, better than most similar companies.
On the Penta Grid this week, Bio-Rad Laboratories, Inc. is Grid #4 of 837 in the Healthcare sector in United States, and Grid #11 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. | 74.33 | 45 | 95 | 99 | 61 | 72 |
| Henry Schein, Inc. | 64.98 | 47 | 79 | 93 | 52 | 54 |
| Vaxcyte, Inc. | 42.70 | 18 | 19 | 71 | 59 | 47 |
| Krystal Biotech, Inc. | 64.56 | 22 | 62 | 83 | 84 | 71 |
| Insulet Corporation | 49.65 | 34 | 73 | 34 | 59 | 48 |
| Oscar Health, Inc. | 65.04 | 41 | 76 | 93 | 68 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 46.15 |
| P/B ratio | 1.36 |
EEarnings
| Trailing EPS | ₹747.30 |
| Forward EPS | — |
NNitro
| Price | 34490.45 |
| 52-week high | 34578.53 |
| 52-week low | 23161.59 |
| Fall from 52-week high | 0.3% |
TTorque
| Return on equity (ROE) | 3.11% |
| Debt-to-equity | 0.19 |
AAnchor
| Beta (price swings) | 1.07 |
| Market cap | ₹92,221 Cr |
| Insider holding | 98.23% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Bio-Rad Laboratories, Inc.'s PosiPenta score?
Bio-Rad Laboratories, Inc.'s PosiPenta is 74.33 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Bio-Rad Laboratories, Inc. stand on the Penta Grid?
On the Penta Grid this week, Bio-Rad Laboratories, Inc. is Grid #4 of 837 in the Healthcare sector in United States, and Grid #11 of 4,000 in United States.
Which PosiPenta pillar is strongest for Bio-Rad Laboratories, Inc.?
Nitro (momentum), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Bio-Rad Laboratories, Inc.?
Price (valuation), with a score of 45 out of 100: around the middle of similar companies.
Has Bio-Rad Laboratories, Inc.'s PosiPenta changed since last week?
Yes, it rose 17.76 points, from 56.57 to 74.33.
PositoAI is for research and education only and is not investment advice.